Levall 5.0 Interactions
There are 730 drugs known to interact with Levall 5.0 (guaifenesin / hydrocodone / phenylephrine), along with 20 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 232 are major, 495 are moderate, and 3 are minor.
- View all 730 medications that may interact with Levall 5.0
- View Levall 5.0 alcohol/food interactions (1)
- View Levall 5.0 disease interactions (20)
Most frequently checked interactions
View interaction reports for Levall 5.0 (guaifenesin / hydrocodone / phenylephrine) and the medicines listed below.
- acetaminophen
- acetaminophen / diphenhydramine / phenylephrine
- Advil (ibuprofen)
- Aerius (desloratadine)
- Airborne (multivitamin with minerals)
- Allegra (fexofenadine)
- alprazolam
- azelastine nasal
- baclofen
- Caltrate 600+D (calcium / vitamin d)
- cannabidiol
- cannabis
- cetirizine
- chlorpheniramine
- Claritin-D (loratadine / pseudoephedrine)
- desogestrel / ethinyl estradiol
- Diflucan (fluconazole)
- diphenhydramine
- eletriptan
- estradiol topical
- ethinyl estradiol / norethindrone
- Flonase (fluticasone nasal)
- ibuprofen
- labetalol
- lisdexamfetamine
- loperamide
- loratadine
- magnesium oxide
- melatonin
- omeprazole
Levall 5.0 alcohol/food interactions
There is 1 alcohol/food interaction with Levall 5.0 (guaifenesin / hydrocodone / phenylephrine).
Levall 5.0 disease interactions
There are 20 disease interactions with Levall 5.0 (guaifenesin / hydrocodone / phenylephrine) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- cardiovascular disease
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
- BPH
- diabetes
- glaucoma
Report options
More about Levall 5.0 (guaifenesin / hydrocodone / phenylephrine)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.